Free Trial

Trevi Therapeutics (TRVI) Institutional Ownership

→ Do This Today BEFORE Biden Wins in November (From Stansberry Research) (Ad)
Free TRVI Stock Alerts
$2.73
-0.19 (-6.51%)
(As of 04:00 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Trevi Therapeutics (NASDAQ:TRVI)

Current
Institutional Ownership
Percentage
95.76%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$3.37M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$4.58M
Get TRVI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

TRVI Institutional Buying and Selling by Quarter

Trevi Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2024 Oppenheimer & Co. Inc.60,415$208K0.0%N/A0.086%
5/7/2024 SG Americas Securities LLC14,592$50K0.0%-85.1%0.021%
5/1/2024 BNP Paribas Financial Markets20,577$71K0.0%-84.4%0.030%
4/25/2024 Rosalind Advisors Inc.926,016$3.20M3.0%-50.3%1.343%
2/15/2024Opaleye Management Inc.2,535,000$3.40M0.9%+48.6%3.970%
2/15/2024Frazier Life Sciences Management L.P.7,381,090$9.89M0.5%+7.3%11.559%
2/5/2024WealthTrust Axiom LLC63,500$85K0.0%-32.1%0.099%
1/12/2024 SG Americas Securities LLC98,253$132K0.0%+401.4%0.154%
1/4/2024 Trust Co. of Toledo NA OH36,502$49K0.0%-68.8%0.057%
11/13/2023Silverarc Capital Management LLC927,415$2.02M0.6%+4.7%1.452%
10/20/2023 Trust Co. of Toledo NA OH117,145$255K0.1%-6.2%0.183%
10/13/2023 SG Americas Securities LLC19,597$43K0.0%N/A0.031%
9/21/2023Barclays PLC14,052$34K0.0%N/A0.022%
8/11/2023VR Adviser LLC3,422,397$8.18M1.3%+12.2%5.697%
8/11/2023Tejara Capital Ltd180,227$431K0.2%-5.3%0.300%
8/4/2023American International Group Inc.20,037$48K0.0%N/A0.033%
8/3/2023Innovis Asset Management LLC43,232$103K0.0%-50.5%0.072%
8/2/2023 MAI Capital Management1,534,652$3.67M0.1%-4.1%2.555%
7/10/2023 Trust Co. of Toledo NA OH124,857$298K0.1%+50.4%0.208%
5/12/2023Tejara Capital Ltd190,218$352K0.2%+26.8%0.317%
5/10/2023 MAI Capital Management1,600,415$2.96M0.0%-7.0%2.664%
4/4/2023 Trust Co. of Toledo NA OH83,000$154K0.0%N/A0.138%
2/10/2023Opaleye Management Inc.485,000$936K0.3%N/A0.809%
2/9/2023 MAI Capital Management1,720,676$3.32M0.1%-14.8%2.872%
2/3/2023Frazier Life Sciences Management L.P.6,663,590$12.86M0.8%+23.3%11.121%
2/2/2023 Bailard Inc.21,200$41K0.0%N/A0.035%
2/1/2023Bank of Montreal Can152,300$294K0.0%N/A0.254%
11/15/2022TPG GP A LLC251,780$388K0.0%-94.2%0.571%
11/14/2022Armistice Capital LLC864,000$1.33M0.0%+107.7%1.961%
11/14/2022Altium Capital Management LP1,066,157$1.64M0.6%-17.0%2.419%
11/14/2022Rubric Capital Management LP5,684,420$8.75M0.4%+219.6%12.899%
11/10/2022Hillsdale Investment Management Inc.86,531$133K0.0%N/A0.196%
11/9/2022Fairmount Funds Management LLC5,696,515$8.77M1.5%+250.7%12.926%
11/7/2022Jump Financial LLC42,977$66K0.0%N/A0.098%
10/28/2022Silverarc Capital Management LLC939,265$1.45M0.5%N/A2.131%
8/15/2022Acuta Capital Partners LLC35,000$98K0.1%N/A0.090%
8/10/2022Frazier Life Sciences Management L.P.1,171,627$3.29M0.3%N/A3.029%
7/27/2022WealthTrust Axiom LLC93,500$262K0.1%-5.1%0.242%
7/19/2022 MAI Capital Management2,040,009$5.73M0.1%+32.3%5.273%
5/10/2022 MAI Capital Management1,541,471$3.39M0.1%N/A3.985%
RSVP: Charles Payne’s Cash Flow Workshop (Ad)

Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.

Register For Free Now!
5/9/2022WealthTrust Axiom LLC98,500$216K0.1%+245.6%0.255%
5/4/2022Commonwealth Equity Services LLC15,000$33K0.0%N/A0.049%
8/17/2021Bridgeway Capital Management LLC34,600$78K0.0%-68.4%0.160%
8/16/2021Alberta Investment Management Corp25,000$56K0.0%N/A0.116%
8/13/2021Renaissance Technologies LLC92,600$208K0.0%-24.0%0.429%
5/21/2021Citadel Advisors LLC10,617$29K0.0%N/A0.053%
5/18/2021Citadel Advisors LLC10,617$29K0.0%N/A0.053%
5/13/2021Renaissance Technologies LLC121,849$330K0.0%+374.1%0.611%
5/7/2021BlackRock Inc.32,394$87K0.0%+40.6%0.163%
4/14/2021WealthTrust Axiom LLC38,500$104K0.0%+234.8%0.193%
3/26/2021Susquehanna International Group LLP14,828$36K0.0%N/A0.081%
2/17/2021Canada Pension Plan Investment Board15,000$36K0.0%N/A0.082%
2/10/2021Renaissance Technologies LLC25,700$62K0.0%N/A0.140%
2/4/2021WealthTrust Axiom LLC11,500$27K0.0%N/A0.063%
8/31/2020Bridgeway Capital Management Inc.100,000$658K0.0%+33.3%0.548%
8/17/2020Omega Fund Management LLC1,375,907$9.05M2.5%+8.9%7.711%
8/14/2020Canada Pension Plan Investment Board40,000$263K0.0%N/A0.224%
8/14/2020TPG Group Holdings SBS Advisors Inc.4,824,883$31.75M0.6%-23.7%27.039%
8/5/2020NEA Management Company LLC5,940,796$39.09M1.6%+33.8%33.293%
5/15/2020Driehaus Capital Management LLC117,371$386K0.0%-6.1%0.658%
(Data available from 1/1/2016 forward)

TRVI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TRVI shares?

During the previous two years, 25 institutional investors and hedge funds held shares of Trevi Therapeutics. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($9.89M), Fairmount Funds Management LLC ($8.77M), Rubric Capital Management LP ($8.75M), VR Adviser LLC ($8.18M), MAI Capital Management ($3.67M), Opaleye Management Inc. ($3.40M), and Rosalind Advisors Inc. ($3.20M).Learn more on TRVI's institutional investors.

What percentage of Trevi Therapeutics stock is owned by institutional investors?

95.76% of Trevi Therapeutics stock is owned by institutional investors. Learn more on TRVI's institutional investor holdings.

Which institutional investors have been buying Trevi Therapeutics stock?

Of the 19 institutional investors that purchased Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Fairmount Funds Management LLC ($4.07M), Rubric Capital Management LP ($3.91M), Frazier Life Sciences Management L.P. ($2.93M), MAI Capital Management ($2.04M), Opaleye Management Inc. ($1.31M), Silverarc Capital Management LLC ($980.76K), and Armistice Capital LLC ($448K).

How much institutional buying is happening at Trevi Therapeutics?

Institutional investors have bought a total of 16,760,875 shares in the last 24 months. This purchase volume represents approximately $30.04M in transactions.

Which Trevi Therapeutics major shareholders have been selling company stock?

Of the 10 institutional investors that sold Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: TPG GP A LLC ($4.07M), Rosalind Advisors Inc. ($936.41K), MAI Capital Management ($484.51K), Altium Capital Management LP ($217.84K), BNP Paribas Financial Markets ($111.63K), Trust Co. of Toledo NA OH ($88.36K), and SG Americas Securities LLC ($83.66K).

How much institutional selling is happening at Trevi Therapeutics?

Institutional investors have sold a total of 6,084,643 shares in the last 24 months. This volume of shares sold represents approximately $11.78M in transactions.


Related Companies:
This page (NASDAQ:TRVI) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners
The ONE AI Stock to own now. (It’s not Nvidia.)
Weiss Ratings
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
This 1 Biotech Stock has been shocking the markets
Huge Alerts
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
Gold Set to EXPLODE!
Gold Safe Exchange
Charles Payne Demystifies Options
Unstoppable Prosperity
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing